| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 11/24/1999 | EP0730470A4 Improved interferon polymer conjugates |
| 11/24/1999 | EP0650366B1 Compositions and methods for treating wounds |
| 11/24/1999 | EP0495091B1 Aica riboside analogs |
| 11/24/1999 | CN1236390A Angiogenic factor and use thereof of treating cardiovascular disease |
| 11/24/1999 | CN1236369A New Knoevenagel condensation products, method for their production and use |
| 11/24/1999 | CN1236367A Benzonaphthyrindines as bronchial therapeutics |
| 11/24/1999 | CN1236362A Azinyloxy- and phenoxy-diaryl-carboxylic derivatives, their preparation and use as mixed ET/ET encothelin receptor |
| 11/24/1999 | CN1236361A N-substituted 2-cyanopyrodlidines |
| 11/24/1999 | CN1236358A Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides |
| 11/24/1999 | CN1235968A Substituted tricyclics |
| 11/24/1999 | CN1235836A Pear syrup for nourishing lungs |
| 11/24/1999 | CN1235833A Novel drug composition for treating and curing and its preparing method |
| 11/24/1999 | CN1046736C 'Delta' 16 unsaturated and (1) heterocyclic steroids useful s steroid (1)-20 lyase inhibitors |
| 11/24/1999 | CN1046732C Enantioselective synthesis of 5,6-dihydro-(S)-4-(ethylamino)-(S)-6-methyl-4H-thieno [2,3-b] thiopyran-2-sulfonamide 7,7-dioxide and related compounds |
| 11/24/1999 | CN1046731C Pyrrolo [2,3-d] pyrimidines and their use |
| 11/24/1999 | CN1046721C Heterocyclic compounds and their preparation and use |
| 11/24/1999 | CN1046715C Process for making HIV protease inhibitors |
| 11/24/1999 | CN1046711C Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
| 11/23/1999 | US5990388 Transgenic plant expressing a cloned dna encoding a vaccinia virus e3l protein at a level to complex and sequester double-stranded rna-like structure of virus/viroid; biological pest control; viricides |
| 11/23/1999 | US5990314 Pharmaceutical pyridine compounds |
| 11/23/1999 | US5990170 Possesses a profile of activity which is similar to, though less potent than .delta.9-thc (tetrahydrocannabinol) with a mimicking of the psychoactive effects; analgesics; side effect reduction; cardiovascular disorders |
| 11/23/1999 | US5990167 Activity-inhibitor and activity-potentiator for glutamic acid in the brain |
| 11/23/1999 | US5990160 In vitro testing of puberulic or puberulonic acid as enzyme inhibitors of inositol monophosphatase; antidepressants for depression and manic depression |
| 11/23/1999 | US5990159 Pharmaceutical formulations comprising a selective serotonin reuptake inhibitors and a 5ht4 receptor antagonists; reduction of gastrointestinal side effects |
| 11/23/1999 | US5990158 Carboxylic acid derivatives, method of manufacturing the same and therapeutic agents containing these compounds |
| 11/23/1999 | US5990155 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease |
| 11/23/1999 | US5990150 Heterocyclic derivatives, method of production thereof and pharmaceutical use thereof |
| 11/23/1999 | US5990149 Photodynamic therapy; using triacid form of the monohydrobenzoporphyrin class; antitumor, carcinogenic, arthritic agents; atherosclerosis; restenosis; blood infections; skin disorders; vision defects |
| 11/23/1999 | US5990148 Side effect reductions; antiarthritic agents; nonsteroidal antiinflammatory agents |
| 11/23/1999 | US5990145 Antiinflammatory,-carcinogenic,-tumor,-metastasis agents; cardiovascular disorders, e.g., arteriosclerosis, restenosis; retinopaathies and nephropathies; osteoporosis |
| 11/23/1999 | US5990142 Antiinflammatory agents and antiallergens having good oral adsorption and bioavailability; cardiotonic and antiischemic agents |
| 11/23/1999 | US5990135 For treating a retroviral infection such as hiv infection; for example 5s-n-((2-pyridinyl)methoxycarbonyl)valinylamino-2-((n-3 -pyridinyl)methoxycarbonyl)amino-4s-hydroxy-1,6-diphenyl-2-azahexane and other compounds of given formula |
| 11/23/1999 | US5990133 Indole derivatives as 5-HT receptor antagonist |
| 11/23/1999 | US5990130 Therapeutic heterocycles |
| 11/23/1999 | US5990128 Administering an antagonist that binds to a human alpha-1c adrenergic receptor with a binding affinity at least 691-fold higher than the binding affinity with which the antagonist binds to a human alpha-1b adrenergic receptor |
| 11/23/1999 | US5990126 Quinolinic sulfide derivatives acting as NMDA receptor antagonists and process for preparation thereof |
| 11/23/1999 | US5990109 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 11/23/1999 | US5990108 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives, preparation thereof, intermediates thereof and drugs containing the same |
| 11/23/1999 | US5990105 Possess a selective affinity to 5ht-6 receptors; treating or preventing psychoses, schizophrenia, manic depressions, depressions, neurological disorders, parkinson's, amyotrophic lateral sclerosis, alzheimer's and huntington's disease |
| 11/23/1999 | US5990104 Inhibiting nmda receptor activation by administering derivatives of given formula, such as 5,6,7,8,9,11,12-heptahydro-3-hydroxy-5-methyl-10-thia-5,11 -methanobenzocyclodecen-13-amine (sulphazocine) |
| 11/23/1999 | US5990102 Substituted azetidin-2-ones for treatment of atherosclerosis |
| 11/23/1999 | US5990099 Treating glc1a glaucoma by administering an angiostatic steroid of given formula |
| 11/23/1999 | US5990083 Composition for reducing cu/zn superoxide dismutase-1 enzyme degradation by inhibiting multicatalytic protease; treating muscle wasting diseases associated with low superoxide dismutase-1 enzyme activity |
| 11/23/1999 | US5989905 HCV NS3 protein fragments having helicase activity and improved solubility |
| 11/23/1999 | US5989864 DNA encoding spo-rel polypeptides |
| 11/23/1999 | US5989863 Human ankyrin family protein |
| 11/23/1999 | US5989856 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins |
| 11/23/1999 | US5989837 Immortalized human keratinocyte cell line |
| 11/23/1999 | US5989832 Method for screening for non-tetracycline efflux pump inhibitors |
| 11/23/1999 | US5989822 Diagnosis and treatment of cancer, neurodegenerative and autoimmune diseases; gene expression |
| 11/23/1999 | US5989804 E6 binding proteins |
| 11/23/1999 | US5989803 Method for treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase |
| 11/23/1999 | US5989554 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
| 11/23/1999 | US5989538 Mpl ligand analogs |
| 11/23/1999 | CA2011587C Nerve growth factor secretion inducing composition |
| 11/23/1999 | CA1340825C Hyaluronic acid fraction for use as a drug delivery system for medicaments |
| 11/21/1999 | CA2238162A1 Tricyclic spiro compounds as 5ht1d receptor antagonists |
| 11/19/1999 | CA2237915A1 Osteoporosis treatment |
| 11/18/1999 | WO1999058947A2 Modulation of molecular interaction sites on rna and other biomolecules |
| 11/18/1999 | WO1999058699A2 Transgenic plant-derived human blood coagulation factors |
| 11/18/1999 | WO1999058692A2 Human apoptosis associated proteins |
| 11/18/1999 | WO1999058691A2 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 11/18/1999 | WO1999058680A2 Method for diagnosis and treatment of haemophilia a patients with an inhibitor |
| 11/18/1999 | WO1999058674A2 Method of inhibiting osteoclast activity |
| 11/18/1999 | WO1999058642A2 Secreted proteins and polynucleotides encoding them |
| 11/18/1999 | WO1999058571A2 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof |
| 11/18/1999 | WO1999058569A1 PLASMIN INHIBITORS FROM THE AUSTRALIAN BROWN SNAKE $i(PSEUDONAJA TEXTILIS TEXTILIS) |
| 11/18/1999 | WO1999058564A1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use |
| 11/18/1999 | WO1999058558A2 Cell signaling proteins |
| 11/18/1999 | WO1999058555A2 Water-soluble pro-drugs of 2,6-diisopropylphenol analogues |
| 11/18/1999 | WO1999058549A1 Meiosis regulating compounds |
| 11/18/1999 | WO1999058533A1 Phenylurea and phenylthio urea derivatives |
| 11/18/1999 | WO1999058531A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 11/18/1999 | WO1999058528A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 11/18/1999 | WO1999058525A1 Indole derivatives as 5-ht2a ligands and as serotonine reuptake inhibitors |
| 11/18/1999 | WO1999058523A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |
| 11/18/1999 | WO1999058522A1 Naphtho[2,3-b]heteroar-4-yl derivatives |
| 11/18/1999 | WO1999058518A2 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 11/18/1999 | WO1999058511A1 Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| 11/18/1999 | WO1999058510A1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 11/18/1999 | WO1999058504A1 Novel 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament |
| 11/18/1999 | WO1999058499A1 Phenylsulfonamide-phenylethylamines useful as dopamine receptors |
| 11/18/1999 | WO1999058496A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 11/18/1999 | WO1999058495A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 11/18/1999 | WO1999058478A1 Novel derivatives of 3,3-diphenylpropylamines |
| 11/18/1999 | WO1999058155A1 Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto |
| 11/18/1999 | WO1999058154A1 Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy |
| 11/18/1999 | WO1999058140A1 Methods to increase white blood cell survival after chemotherapy |
| 11/18/1999 | WO1999058139A2 Methods for detecting and inhibiting angiogenesis |
| 11/18/1999 | WO1999058132A1 Use of a farnesyl transferase inhibitor in the manufacture of a medicament for local administration to the vascular wall in the prevention of restenosis |
| 11/18/1999 | WO1999058130A1 New drug combinations of a n.a.r.i., preferably reboxetine, and pindolol |
| 11/18/1999 | WO1999058128A1 Inhibition of protein kinases with piridinylimidazoles |
| 11/18/1999 | WO1999058123A2 Novel fatty acid analogues for the treatment of primary and secondary restenosis |
| 11/18/1999 | WO1999058122A1 Novel fatty analogues for the treatment of diabetes |
| 11/18/1999 | WO1999058121A1 Novel fatty analogues for the treatment of obesity, hypertension and fatty liver |
| 11/18/1999 | WO1999058120A1 USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS |
| 11/18/1999 | WO1999058098A2 HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO |
| 11/18/1999 | WO1999058096A2 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis |
| 11/18/1999 | WO1999058095A2 Pharmaceutical and/or cosmetic compositions containing sea water |
| 11/18/1999 | WO1999057981A1 Compositions and methods for active vaccination |